GLASDEGIB vs VISMODEGIB: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
GLASDEGIB vs VISMODEGIB: Safety Overview
| Metric | GLASDEGIB | VISMODEGIB |
|---|---|---|
| Total FAERS Reports | 521 | 8,135 |
| Deaths Reported | 196 | 864 |
| Death Rate | 37.6% | 10.6% |
| Hospitalizations | 275 | 974 |
| Average Patient Age | 67.4 yrs | 69.6 yrs |
| % Female Patients | 38.6% | 39.3% |
| FDA Approval Date | Nov 21, 2018 | Jan 30, 2012 |
| Manufacturer | Pfizer Laboratories Div Pfizer Inc | Genentech, Inc. |
| Route | ORAL | ORAL |
| Marketing Status | Prescription | Prescription |